LAUREN BACHMAN: Open Payments
NPI 1902312770 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 28 payments from 14 companies in 2025. Trend: 2023 $987 · 2024 $2,360 · 2025 $1,438
Food & beverage: $1,338Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $284 |
| Janssen Biotech, Inc. | 4 | $284 |
| Incyte Corporation | 3 | $260 |
| Gilead Sciences, Inc. | 2 | $250 |
| Merck Sharp & Dohme LLC | 3 | $158 |
| Stemline Therapeutics Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| SOBI, INC | 1 | $20 |
Products named: Enhertu, RYBREVANT, KEYTRUDA, JAKAFI, Trodelvy, Monjuvi, ELZONRIS, Onivyde.
Industry payments across PA — which companies pay providers there.
